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Abstract 
A retrospective review for diabetes was performed on 1,055 randomly selected patient records, of which 
122 records were diabetic patients, at an urban optometric clinic. The purpose of this retrospective study 
was to create a profile of diabetic patients that may aid health care professionals in identifying eye health 
risk factors in patients, allowing for early detection of ocular pathology and prevention of blindness. 
Several factors including age, ethnicity, family history, accompanying ocular and systemic conditions, 
prevalence of diabetic retinopathy, and clinical care provided were analyzed. The following trends were 
noted using frequency histogram analysis: Over 95% of diabetic patients had Type 2 diabetes; the Latino 
population had a higher prevalence of diabetes up to age forty; after age forty, Latinos and African 
Americans showed an equal prevalence of diabetes; maternal and sibling family history showed the 
greatest association with diabetes; hypertension had the strongest systemic association with diabetes, 
followed by heart disease and high cholesterol; cataracts displayed the highest ocular association; 
medication other than insulin was the most utilized form of diabetes control; the average reported 
glucose reading was 178 mg/dl, while the average measured in-office reading was 207 mg/dl; the 
prevalence of diabetic retinopathy proved to be inversely related to the severity of the retinopathy. 
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Abstract 
A retrospective review for diabetes was performed on 1,055 randomly selected patient 
records, of which 122 records were diabetic patients, at an urban optometric clinic. The 
purpose of this retrospective study was to create a profile of diabetic patients that may aid 
health care professionals in identifying eye health risk factors in patients, allowing for 
early detection of ocular pathology and prevention of blindness. Several factors 
including age, ethnicity, family history, accompanying ocular and systemic conditions, 
prevalence of diabetic retinopathy, and clinical care provided were analyzed. The 
following trends were noted using frequency histogram analysis: Over 95% of diabetic 
patients had Type 2 diabetes; the Latino population had a higher prevalence of diabetes 
up to age forty; after age forty, Latinos and African Americans showed an equal 
prevalence of diabetes; maternal and sibling family history showed the greatest 
association with diabetes; hypertension had the strongest systemic association with 
diabetes, followed by heart disease and high cholesterol; cataracts displayed the highest 
ocular association; medication other than insulin was the most utilized form of diabetes 
control; the average reported glucose reading was 178 mg/dl, while the average measured 
in-office reading was 207 mg/dl; the prevalence of diabetic retinopathy proved to be 
inversely related to the severity of the retinopathy. 
Key Words: diabetes mellitus, diabetic retinopathy, survey, profile, epidemiology, 
prevalence, demographics. 
Introduction 
Diabetes mellitus is a significant and chronic health care problem in the United States. 
Over 15.7 million Americans have diabetes; 10.3 million cases are diagnosed in this 
country, while 5.4 million people remain undiagnosed. Every year, doctors diagnose 
nearly 800,000 new cases of diabetes in this country.' 
Diabetes is a serious disease condition with vascular complications including diabetic 
neuropathy, nephropathy, and retinopathy. The direct and indirect health care costs of 
diabetes in this country are astonishing. Greater than $44 billion was spent on direct 
health care costs associated with diabetes in 1997, while more than $54 billion was spent 
on indirect costs, including disability, work loss, and premature mortality. In recent 
years, one dollar of every seven dollars spent on health care in the U.S. was for diabetes - 
mostly for complications of the disease.' 
As more patients are diagnosed with diabetes each year, there is a subsequent increase of 
cases of diabetic retinopathy. Diabetic retinopathy causes 12,000 to 24,000 new cases of 
blindness annually, and at least 50,000 Americans are legally blind as a result of diabetic 
r e t i n ~ ~ a t h ~ . ~  Therefore, visual health care professionals play an important role in the 
diagnosis and management of diabetes, via careful ocular anterior and posterior segment 
evaluations. Early diagnosis, along with consistent follow up and intensive treatment, is 
an important component of managing diabetes, and can also play a role in preventing 
blindness. " Intensive treatments to maintain blood glucose concentrations close to the 
normal range have been shown to decrease the risk of the development of diabetic 
retinopathy by seventy-six percent." 
Recent studies, including the Diabetic Retinopathy Study (DRS), Early Treatment 
Diabetic Retinopathy Study (EDTRS), and Diabetic Retinopathy Vitrectomy Study 
(DRVS) have revealed that early referral and eye care treatment play important roles in 
reducing the risk and decreasing vision loss caused by d i a b e t e ~ . ~ . ~ . ~  Early intervention is 
especially important for Latino and African American patients, as one study found that 
over 42% of Latino patients and 37% of African American patients demonstrate signs of 
significant diabetic retinopathy at the time their diabetes is diagnosed.7 
The ocular complications of diabetes are not strictly limited to retinopathy. In fact, 
patients with diabetes are also at increased risk of developing cataracts and glaucoma. 
Approximately 5% of patients with diabetes also develop glaucoma, while the rate of 
glaucoma in non-diabetic patients is close to 2%.' Also, cataracts occur two to four 
times more often in diabetic patients than in patients without diabetes. With diabetes, 
cataracts tend to develop at younger ages and progress more rapidly. The incidence of 
these ocular complications increases with age and duration of the d i ~ e a s e . ~  
The purpose of this retrospective study was to create a profile of diabetic patients at an 
urban primary care optometric practice in Northeast Portland, Oregon. This information 
may aid health care professionals in identifying possible eye health risk factors in 
patients, allowing for early detection of ocular pathology and prevention of blindness. It 
may also provide health care providers with insight regarding the ocular complications 
and management of diabetes, as well as coinplementing the current literature base on 
diabetes and its oculx seqnelac. 
Methods 
A retrospective study was performed on 1,055 randomly selected patient records from the 
primary care clinic of the Pacific University College of Optometry located in Northeast 
Portland, Oregon. Each record reviewed was assigned an individual identification 
number to ensure patient confidentiality. The following information was recorded for all 
records reviewed: Date of Birth, Gender> and Ethnicity. 
From the  1,055 records, diabetic patient records were identified and reviewed in greater 
detail. Only current comprchcnsive vision examinations with last exam dates of at least 
one month prior to the start of the study were reviewed. This was to ensure that diabetic 
patients had completed their current care and were not being treated during data 
collection. The information was gathered and entered into the Microsoft Access 2000 
database program for maIysis. Figure 1 shows the database layout for the study and the 
data that was gathered for each record: 
Figure 1. Example of Diabetic Profile Database Form 
Each diabetic patient record was reviewed for the following information: 
1. Date of Birth 
2. Gender 
3. Ethnicity (CaucasianIEuropean, Latino, Asian, African, East Indian, African 
American, Native American, Other, Not Documented) 
4. Type of Diabetes (Type 1, Type 2) 
5. Age at Onset 
6. Date of Exam 
7. Duration of Diabetes 
8. Family History of Diabetes (Mother, Father, Siblings, Grandparents, Other) 
9. Control of Diabetes (Insulin dependant, Insulin, Medication, DietIExercise) 
10. Intraocular Pressure (IOP) 
1 1. Blood Pressure 
12. Cataracts (Nuclear sclerosis, Cortical, Posterior Subcapsular, Other, None) 
13. Glucometry Performed (mgldl level, measured by One-Touch glucometer) 
14. Blood Glucose Level (subjective) 
1 5. Glaucoma Diagnosed 
16. Best Corrected Visual Acuities 
17. Non-proliferative Diabetic Retinopathy (NPDR) Present 
18. Proliferative Diabetic Retinopathy (PDR) Present 
19. Consultation Sent to Primary Care Provider 
20. Other Medical Conditions (Heart, Respiratory, Hematological, Thyroid, 
Neurological, Skeletal, Gastrointestinal, Endocrine, Cancer, Hypertension, 
Cholesterol, Liver, Other) 
2 1. Referral Made 
22. Fluorescein Angiography Performed 
23. Treatment Performed (Pan-Retinal, Photocoagulation, Focal Laser) 
24. Frequency of Follow-Up (3 months, 6 months, 1 year, 1.5 years, 2 years) 
Results 
Of the 1,055 patient records reviewed, there were 60.3% females and 39.7% males. The 
ethnic distribution of the Northeast clinic population is shown in Figure 2 below. 
Figure 2. Ethnic Distribution of all Patients 
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A total of 122 patients were identified as being diagnosed with diabetes, which 
constitutes 1 1.6% of the Northeast clinic patient population. The average age of onset of 
diabetes was 46.8 years with an average duration of 6.9 years and standard deviation of 
6.1 years. There were 59.8% female and 40.2% male diabetic patients. These gender 
findings correspond to the overall patient distribution and provide no correlation between 
gender and diabetes. Of the 11.6% overall diabetic patients, Type 2 (95.1%) was more 
prevalent than Type 1 (4.9%). 
Figure 3 below shows the percentage of diabetic patients with a positive family history of 
diabetes. The highest prevalence of diabetes occurred when the patient's mother had a 
history of diabetes (1 8.0%), followed by a positive history reported among siblings 
(1 5.6%), and then father (1 3.1 %). The "other" category included aunts, uncles, cousins, 
etc. and accounted for 9.8%, while patients who had a grandparent with a history of 
diabetes showed 7.4% prevalence. 
Figure 3. Family History Profile of Diabetes as Related to Percentage of Diabetic Patients 
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Because Type 2 diabetes has a higher prevalence than Type 1 diabetes, and because Type 
2 diabetes generally affects those over age forty, this study next examined the Northeast 
diabetic patient population over age forty in greater detail. Of the 1,055 patient records 
reviewed, 397 (37.6%) patients were over age forty. Diabetes had been diagnosed in 110 
(27.7%) of these patients and greater than 99% of these patients had Type 2 diabetes. 
The average age of onset of Type 2 diabetic patients over age forty was 48.9 years of age, 
with an average duration of 6.7 years and a standard deviation of 10.4 years. There were 
61.8% females and 38.2% males over age forty with diabetes. 
In 26.2% of diabetic patients of all ages ethnicity whs not documented. The ethnicities 
with the highest prevalence of diabetes were Latino (26.2%), Afncan American (23.8%), 
and CaucasianIEuropean (15.6%). In diabetic patients over age forty, ethnicity was not 
documented in 26.4% of records. The ethnicities with the highest prevalence of diabetes 
in these records were Latino and Aji-ican American (24.6% each) and 
CaucasianIEuropean (1 6.4%). The ethnic distributions of diabetic patients of all ages and 
of diabetic patients over age forty are illustrated in Figures 4 and 5, respectively. 
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Figure 4. Percentage of All Diabetic Patients as Related to Ethnicity 
Figure S. Percentage of Diabetic Patients Over Age Forty as Related to Ethnicity 
Consideration of systemic health characteristics in patients diagnosed with diabetes was 
also an important aspect of this retrospective study. As demonstrated by Figure 6 below, 
60.9% of the diabetic patients over age forty profiled in this study had accompanying 
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'The manner in which the doctor and patient decide to control and monitor diabetes is also 
an important factor to consider when c d n g  a profile of diabetic patients. 
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of the diabetic patients rely on insulin to control their diabetes, while 10% of patients 
control their diabetes with diet and exercise. The method of control was "unknown" in 
the final 10% of patient records reviewed. Figure 7 illustrates the frequency of use of 
each of the methods of control. 
Figure 7. Distribution Pie of Diabetic Control Methods in 
Diabetic Patients Over Age Forty 
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Figure 9. Percentage of Diabetic Patients with Retinopathy 
as Related to Duration of Diabetes 
Of the 122 diabetic patient records reviewed, 103 (84.4%) letters were sent to the 
patient's primary care provider relating the exam findings. Patient education regarding 
diabetes and the ocular exam findings was documented in 82.0% of the records,reviewed. 
A referral for further treatment of diabetic retinopathy was documented in 6.6% of the 
diabetic patient records reviewed in this retrospective study. The majority (62.5%) of 
these referrals were for CSME. Figure 10 shows the follow-up interval documented in 
the patient records. One year follow-up was recommended in 62.3% of the records, 
while 18.0% of the patient records reviewed contained documentation suggesting three 
month follow-up. 
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Figure 10. Follow-Up Visit Intervals for Diabetic Patients 
When glucose levels were measured and recorded at the time of the vision examination in 
this test population, the average reading was 207.1 mgldl with a standard deviation of 
90.1 mgldl. The measurements ranged from 76 mgldl to 377 mgldl, demonstrating a 
large variation in glucose levels among patients. When the patient simply reported 
hislher average glucose level to the intern, rather than the intern actually measuring the 
level, the average value was 178.7 mgldl, with a standard deviation of 67.0 mgldl. The 
patients' reported glucose levels ranged from 74 mgldl to 370 mgldl. 
As stated above, the three most common systemic complications that accompanied 
diabetes in the patients in this population were hypertension, heart disease, and high 
cholesterol. The glucose levels of patients with these health conditions were analyzed to 
determine if these patients have a higher plasma glucose concentration. When a patient 
reported a diagnosis of hypertension and glucometry was performed, the average reading 
was 229.5 mgldl with a standard deviation of 86.4 mgldl. The measurements ranged 
from 95 mgldl to 377 mgldl. Patients with a history of heart disease who had their 
glucose levels measured at the time of their vision examination had an average reading of 
193 mgldl with a standard deviation of 99.8 mgldl. Finally, when high cholesterol was 
reported, the average reading was 139 mgldl, with a standard deviation of 12.7 mgldl. 
The raw data from the 122 diabetic patient records is available in Appendix A. 
Discussion 
This was a retrospective study profiling a diabetic population. Since this was a small 
clinical population, one would expect a higher prevalence of diabetes than for the general 
population. The American Diabetes Association reports that 5.9% of the general 
population has diabetes.' This Northeast Portland clinic population has an 1 1.6% 
prevalence of diabetes, which is higher than the national level. This can be attributed, in 
part, to the higher rate of ethnic diversity within this population as compared to the 
general population.10 It has been shown in prior studies that Latinos, African Americans, 
and Native Americans have a higher prevalence of diabetes. 11,12,13 The higher prevalence 
of diabetes in this urban optometric clinic may also be explained by the fact that this 
clinic serves a higher-need indigent population. 
The American Diabetes Association states that Type 1 diabetes accounts for 
approximately 5-10% of the diabetic population in the United States, while Type 2 
diabetes comprises approximately 90-95%.' This study showed a prevalence of 4.9% 
Type 1 diabetes and 95.1 % Type 2 diabetes among all diabetic patients at the Northeast 
clinic. Research also indicates that diabetes increases with age and that Type 2 diabetes 
primarily affects individuals over age forty.14 This retrospective study examined Type 2 
diabetes in individuals over age forty more closely. The prevalence of diabetes increased 
to 27.7% in patients over age forty at the Northeast clinic, demonstrating a noticeable 
increase in the prevalence of diabetes in this age group. 
Since the prevalence of diabetes in the United States is high and markedly affects the 
quality of life in those affected, it is important to determine factors that increase the risk 
of developing diabetes. This retrospective study examined the prevalence of family 
history among diabetic patients. Some of the findings in this study confirm previous 
research and clinical expectations. A previous study showed that a mother or father with 
diabetes influences the development of diabetes by 16.0% and that the mother's diabetes 
history is most significant.15 The Northeast clinic population supports the findings that 
maternal or paternal diabetes history plays a role in the risk of developing diabetes. In 
addition, this study also showed that siblings with diabetes may play a role in the risk of 
developing diabetes. No studies are currently available that indicate the prevalence of 
diabetes in other family members and link this to a risk of developing diabetes. 
This retrospective study also examined the frequency of diabetes accompanied by 
additional systemic conditions in this clinic population. The most significant results, in 
order of frequency, were hypertension, heart disease, and high cholesterol. Hypertension 
is most common in patients with Type 2 diabetes, as reported by the United Kingdom 
Prospective Diabetes Study (UKPDS).'~  his study found that 38% of patients recently 
diagnosed with Type 2 diabetes also had hypertension. The study also verified that the 
incidence of hypertension continues to increase years after diagnosis of diabetes.17 
Another study found that 21.7% of the patients interviewed reported a positive history of 
high blood pressure.'5 
Cardiovascular disease is the principal cause of morbidity, disability, and mortality in 
patients with Type 2 ~ i a b e t e s . ' ~  Research done by Stem and Haffner (1991) also 
suggests a need to control lipid levels to prevent diabetic complications. Their research 
states that complications of diabetes may be reduced by control of blood lipid levels, 
especially triglycerides. ' 
Currently, the American Optometric Association recommends blood glucose screenings 
on those individuals identified as being at a high risk of developing diabetes.19 The 
American Diabetes Association states obesity, hypertension, a family history of diabetes, 
as well as certain ethnic backgrounds, place individuals at an increased risk of diabetes." 
Diabetes should be suspected when symptoms of diabetes exist, along with a casual 
plasma glucose concentration greater than or equal to 200 rng/dl.'' This measurement is 
taken without consideration of when the patient last ate a meal. This is the scenario most 
often encountered in an optometric clinic, as patients do not consider fasting for glucose 
measurements to be made at this appointment. 
The blood glucose measurements performed on this clinic population were casual plasma 
glucose levels. These measurements were made using a One-Touch glucometer system. 
Measurements were often performed when the patient was unaware of their current blood 
glucose level or if a history of poor control was demonstrated. The Northeast clinic 
population demonstrated an average casual plasma glucose level of 207 mgldl and ranged 
as high as 377 mgldl. These measurements exceed the level at which a recommendation 
for further evaluation is needed. This implies that important information could be gained 
from routine casual plasma glucose levels in high-risk patients and may provide eye care 
professionals with an additional tool to further manage diabetic patients. 
Diabetes can impact many aspects of visual function. Diabetic retinopathy is the leading 
cause of blindness and visual disability in individuals between the ages of 20-74 in the 
United s tates.9322123 One of the most significant aspects to consider regarding diabetic 
retinopathy is the amount of time the patient has been diagnosed with the disease, as a 
steady increase in rates and severity of retinopathy occur with an increased duration of 
diabetes.9922323 
Table 1 below indicates the duration of Type 2 diabetes and the corresponding prevalence 
of diabetic retinopathy standards, which are published and available for review by eye 
care professionals.19 
Table 1. Prevalence of Diabetic Retinopathy as Related to Duration of Type 2 Diabetes 
Duration of Type 2 Diabetes 
0-4 years 
5-9 years 
10-14 years 
> 15 years ,- 
Prevalence of Diabetic Retinopathy 
31 % 
32% 
38% 
51 % ..- 
When examining the results of the retrospective profile of diabetic patients at the 
Northeast Portland clinic, it can be seen that the prevalence of retinopathy is lower at 
each level of duration. While the American Optometric Association's data shows an 
increase in retinopathy with increased duration of diabetes, the prevalence of retinopathy 
did not progress in the same manner at the Northeast Portland optometric clinic. In fact, 
in the population at the Northeast clinic, the highest prevalence of retinopathy was seen 
in patients with a five to nine year duration of diabetes. 
Despite the reduced prevalence of diabetic retinopathy at the Northeast clinic, it is 
important to note that appropriate follow up and management was documented for 
patients exhibiting signs of retinopathy. This complies with the standards established by 
the Diabetic Retinopathy Study and Early Treatment Diabetic Retinopathy Study, which 
emphasize the importance of early intervention to reduce the risk of severe vision l ~ s s . ~ , ~  
Conclusion 
The information obtained from this retrospective study of diabetic patient records at 
Pacific University's Northeast Portland optometric clinic showed several significant 
trends. The following trends are the most noteworthy. 
The most prevalent ethnicities found among all patients at the Northeast clinic 
were Latino, African American, and CaucasianEuropean respectively. However, 
when looking at the ethnic distribution of patients over age forty with diabetes, 
Latinos and African Americans showed an equal prevalence. This shows an 
increase in diabetes prevalence among African Americans over age forty. 
Because a large portion of the reviewed records did not contain documentation of 
ethnicity, the results of this study indicate an increased need to document this 
information in patient records. Ethnicity may indeed contain information 
regarding the patient's risk of developing diabetes in this population. 
Maternal and sibling history of diabetes showed the most frequent association 
with diabetes. 
A wide range of blood glucose levels was found in the diabetic patient population 
at the Northeast clinic. The data reveals that when patients report their average 
glucose level, the average level was nearly 30 mgldl lower than when blood 
glucose levels were measured at the optometric clinic. This finding may indicate 
that when an individual is aware of hisher glucose reading, there is also better 
compliance with medication and lifestyle control. The wide range found in the 
measured glucose readings suggests the importance of glucometry readings in 
individuals at risk of diabetes and in individuals with a history of poor control. 
Diabetic retinopathy occurred with the greatest frequency after a duration of 
diabetes of five to nine years. Mild and moderate NPDR had the greatest 
prevalence in this population, while severe NPDR and PDR were rarely seen in 
this patient population. One reason for this may be that patients with a longer 
duration of diabetes and more severe forms of retinopathy are regularly seen by 
tertiary care specialists. 
All patients at the No~qheast clinic with signs of CSME were referred 
immediately, regardless of the level of dinbetic retinopathy. This complies with 
current clinical standards of carc for diabetic patients. 
The diabetic patient records reviewed showed a high rate of correspondence of 
ocular exam findings to the patient's primary care physician. Dncurncntation of 
patient education regarding the examination findings was also high. h c h  of these 
aspects is essential to ensure that patients are receiving the best complete care and 
management of their diabetes. However, documentation of education and 
consul tation should occur on each and every diabetic patient record, 
It is hoped that the information from this study provides the reader with a further 
understanding of diabetes, with reg& to both tbe associated health factors and patient 
management. In particular, this study attempts to bring greater familiarization of 
pertinent evaluation considerations and provide information to aid in the management of 
diabetic patients from a clinical eye cam perspective. 
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Facts abozit Te injzlm'es 
and ye yedep in the coal 
mining indzlshy: 
EYE INJURIES 
1534 eye injuries occurred in the 
rmning industry during the years 1986- 
1995. 
Eye injuries account for 11% of all 
non-strain injuries that occur in this 
industry. 
Nearly 3 out of 5 workers who 
suffered eye injuries were not wearing 
eye protection at the time of the 
accident. 
EYE SAFETY 
Employees cite several reasons for 
noncompliance regardmg safety 
glasses, includmg blurred vision, 
poor fit of safety glasses, fogging, 
and glare. 
Despite the fact that the majority of 
mine employees understand the 
importance of safety eyewear, one 
survey suggests that nearly halfof 
the respondents wore their eyewear 
less than half of their shift and 
another 4% stated that they never 
wore them. 
Cori D. Callahan 
Keri J. Cochran 
Pacific University College of Optometry 
Forest Grove, Oregon 
503.357.61 51 
OCCUPATIONAL VISION 
CARE PROGRAM. 
EYECARE FOR THE COAL 
MLNNGINDUS?7RY 
- r MINING , 
BENEF'ITS OF 
A VISION 
CARE 
PROGRA1LI 
As in any industry, eye safety 
and protection are important issues in 
coal mining. Currently, many mining 
companies have a policy of wearing 
safety glasses full-time in all work 
areas, while others require safety 
glasses only where required by 
MSHA. However, due to fogging, 
blurry vision, poor fit, and other 
impediments of safety eyewear, 
employee noncompliance can be a 
troubhng issue. 
Many mine managers are not 
aware of occupational optometry and 
the benefits of implementing a vision 
care program. Occupational 
optometry is a specialized group of 
optometrists that work with 
managers and employees to design 
programs that meet the increasing 
needs of modem industry. This 
vision care profession has the ability 
to perform complete visual 
diagnoses, prescribe and design 
lenses, and fit and maintenance 
eyewear to meet the functional 
requirements of the workplace. 
SERVICES OF AN 
OCCUPATIONAL 
OPTOMETRIST 
Provide vision examinations for all 
elqqble employees. These should be 
performed before, during, and at the 
end of employment. 
Prescribe, provide, fit, and maintain all 
protective eyewear for employees that 
work in underground and surface 
areas, as well as employees that weld, 
cut, or grind materials. 
Provide prescription and computer 
glasses for employees that work in 
office environments. These glasses are 
aimed at maximking visual 
performance and improving 
productivity. 
Consult with management regarding 
MSHA eye safety requirements and 
ANSI standards. 
Initiate on-site eye safety workshops 
for supervisors and employees. 
Offer recommendations to 
management regarding the most 
appropriate type of safety eyewear for 
each employment position. 
Tour mining fadties to determine eye 
hazards and become familiar with 
visual tasks associated with each job to 
better manage each employee. 
Treat ocular injuries and remove 
f o r e p  bodies. 
BENEFITS OF CONTRACTING 
WITH AN OCCUPATIONAL 
OPTOMETRIST 
Costs of eye care to the company 
can be greatly reduced. A contract 
allows each examination, as well as 
quality materials and additional 
professional and a k s t r a t i v e  
services, to be provided for less than 
if every employee sought vision care 
independently. 
Procedures for providmg eye care to 
ehgible employees wdl be simplhed. 
Clear vision and comfortable fit 
ensures longer wearing time and 
improved comphnce with safety 
measures. 
Proper documentation of previous eye 
health and visual acuity wdl be 
available. T h s  is necessary in 
determining the percent of vision loss 
If an accident were to occur. 
Management can rest assured that all 
applicable industrial standards, such as 
those outlined by MSHA and ANSI, 
will be met or exceeded. 
Options will be offered that further 
increase efficiency and employee 
comphnce, such as improved anti-fog 
and anti-scratch coatings. 
Occupational optomet y provides a complete 
vision care program that could reduce 
accident rates and improve eficiency. 
